2101 - 2125 of 8801 Results
Title
Year
-
OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://doi.org/10.7554/elife.91645Citation Count: 50
-
OPENTitle: A high-resolution map of the human small non-coding transcriptomeJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 10Start Page: 1621End Page: 1628Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/34/10/1621/25118245/btx814.pdfCitation Count: 26
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 41
-
OPENTitle: LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorderJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 98End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.019Best OA location URL: https://escholarship.mcgill.ca/concern/articles/pk02cg25sCitation Count: 32
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 4
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
-
OPENTitle: Low plasma serotonin linked to higher nigral iron in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-03700-2Best OA location URL: https://www.nature.com/articles/s41598-021-03700-2.pdfCitation Count: 13
-
RESTRICTEDTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: http://doi.org/10.1016/j.parkreldis.2024.107118Citation Count: 0
-
OPENTitle: Initiating pharmacotherapy in early Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30225-8Best OA location URL: https://pure.amc.nl/en/publications/initiating-pharmacotherapy-in-early-parkinsons-disease(38fe3866-cce3-4a08-934a-d979a3cec1cc).htmlCitation Count: 5
-
OPENTitle: Non-Motor Symptoms as Markers of Disease Severity in Parkinson’s Disease: Associations Between Constipation, Depression, REM Sleep Behavior Disorder, and Motor ImpairmentJournal Name: BiomedicinesPublisher: MDPI AGVol: 13Issue #: 11Start Page: 2704End Page: 2704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3390/biomedicines13112704Best OA location URL: https://www.mdpi.com/2227-9059/13/11/2704/pdf?version=1762184201Citation Count: 0
-
OPENTitle: Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiencyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf369Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf369/64356002/fcaf369.pdfCitation Count: 0
-
OPENTitle: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein FibrilsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 15Start Page: 6002End Page: 6017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571Best OA location URL: http://doi.org/10.1021/acs.jmedchem.5b00571Citation Count: 107
-
RESTRICTEDTitle: Neuropsychological impairment in prodromal Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 371Issue #:Start Page: 117End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007Citation Count: 14
-
OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 20
-
OPENTitle: The good and bad of therapeutic strategies that directly target α‐synucleinJournal Name: IUBMB LifePublisher: WileyVol: 72Issue #: 4Start Page: 590End Page: 600Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/iub.2194Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iub.2194Citation Count: 15
-
OPENTitle: Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e0317566End Page: e0317566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0317566Best OA location URL: https://doi.org/10.1371/journal.pone.0317566Citation Count: 1
-
RESTRICTEDTitle: Normal and pathological neuronal distribution of the human mesencephalic locomotor regionJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 218End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27578Citation Count: 35
-
RESTRICTEDTitle: The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 262Issue #: 11Start Page: 2443End Page: 2447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-015-7868-3Citation Count: 25
-
OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease2021OPENTitle: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023Best OA location URL: http://www.prd-journal.com/article/S1353802021002431/pdfCitation Count: 29
-
RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 14
-
OPENTitle: A cholinergic contribution to postural control and freezing of gait in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3110End Page: 3111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad223Best OA location URL: https://academic.oup.com/brain/article-pdf/146/8/3110/51018614/awad223.pdfCitation Count: 0
-
RESTRICTEDTitle: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonistJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 398Issue #: 1Start Page: 991End Page: 1002Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0Best OA location URL: https://hal.science/hal-04932477Citation Count: 1
-
RESTRICTEDTitle: Dopamine receptors D3 and D5 regulate CD4+T-cell activation and differentiation by modulating ERK activation and cAMP productionJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 284Issue #:Start Page: 18End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2015.05.003Citation Count: 47
-
RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 43